GENFIT and LabCorp Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver DiseaseExclusive Licensing Agreement • September 27th, 2020
Contract Type FiledSeptember 27th, 2020• Innovative multi-biomarker blood test based on GENFIT’S NIS4™ technology is specifically designed to identify patients with at-risk non-alcoholic steatohepatitis (NASH)